IRIS Accounts Production v24.2.0.383 10389610 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103896102023-01-31103896102024-01-31103896102023-02-012024-01-31103896102022-01-31103896102022-02-012023-01-31103896102023-01-3110389610ns15:EnglandWales2023-02-012024-01-3110389610ns14:PoundSterling2023-02-012024-01-3110389610ns10:Director12023-02-012024-01-3110389610ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3110389610ns10:SmallEntities2023-02-012024-01-3110389610ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3110389610ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3110389610ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3110389610ns10:AbridgedAccounts2023-02-012024-01-3110389610ns10:Director22023-02-012024-01-3110389610ns10:RegisteredOffice2023-02-012024-01-3110389610ns5:CurrentFinancialInstruments2024-01-3110389610ns5:CurrentFinancialInstruments2023-01-3110389610ns5:Non-currentFinancialInstruments2024-01-3110389610ns5:Non-currentFinancialInstruments2023-01-3110389610ns5:ShareCapital2024-01-3110389610ns5:ShareCapital2023-01-3110389610ns5:RetainedEarningsAccumulatedLosses2024-01-3110389610ns5:RetainedEarningsAccumulatedLosses2023-01-3110389610ns5:PlantMachinery2023-02-012024-01-31
REGISTERED NUMBER: 10389610 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

Mijo Healthcare Limited

Mijo Healthcare Limited (Registered number: 10389610)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Mijo Healthcare Limited

Company Information
for the Year Ended 31 January 2024







DIRECTORS: Ms J Sinclair
Mrs M Doolan





REGISTERED OFFICE: Chancery House
41a Hanger Hill
Weybridge
Surrey
KT13 9XZ





REGISTERED NUMBER: 10389610 (England and Wales)





ACCOUNTANTS: Ampersand Partnership Limited
Chancery House
41a Hanger Hill
Weybridge
Surrey
KT13 9XZ

Mijo Healthcare Limited (Registered number: 10389610)

Abridged Balance Sheet
31 January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,396 858

CURRENT ASSETS
Stocks 89,706 101,532
Debtors 91,854 59,075
Cash at bank 48,405 77,704
229,965 238,311
CREDITORS
Amounts falling due within one year 110,173 157,982
NET CURRENT ASSETS 119,792 80,329
TOTAL ASSETS LESS CURRENT LIABILITIES 121,188 81,187

CREDITORS
Amounts falling due after more than one
year

26,530

35,558
NET ASSETS 94,658 45,629

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 94,656 45,627
SHAREHOLDERS' FUNDS 94,658 45,629

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Mijo Healthcare Limited (Registered number: 10389610)

Abridged Balance Sheet - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 January 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 October 2024 and were signed on its behalf by:





Ms J Sinclair - Director


Mijo Healthcare Limited (Registered number: 10389610)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Mijo Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on the going concern basis which assumes that the company will continue as a going concern for the foreseeable future. The validity of this assumption depends on the continuing support of the company creditors to provide adequate financial support and by not seeking repayment of amounts owed to them. The directors have no reason to believe this support is not forthcoming and accordingly believe it appropriate to prepare the financial statements on the going concern basis.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Mijo Healthcare Limited (Registered number: 10389610)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 February 2023 24,001
Additions 2,084
Disposals (22,721 )
At 31 January 2024 3,364
DEPRECIATION
At 1 February 2023 23,143
Charge for year 1,546
Eliminated on disposal (22,721 )
At 31 January 2024 1,968
NET BOOK VALUE
At 31 January 2024 1,396
At 31 January 2023 858

5. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

M Doolan - a director

At the year end the amount owed by the company to M Doolan was £19,999 (2023: £19,999).

J Sinclair - a director

At the year end the amount owed by the company to J Sinclair was £27,064 (2023: £43,214).